Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bizverse.World - the metaverse for business attracts global investments concurrently from 6 ventures and partners 2022-06-07 19:00
Payfor: How a Financial Specialist Co is saving thousands of SMEs from closing 2022-06-07 18:03
Molecular Stethoscope, Inc. announces new investment from the Alzheimer's Drug Discovery Foundation 2022-06-07 18:00
Yuchai Establishes New Engine Service Joint Venture 2022-06-07 18:00
Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2022 2022-06-07 16:10
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand 2022-06-07 16:00
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand 2022-06-07 16:00
BRV China-backed eVTOL Start-up Zerog Closes Nearly RMB10 Million Seed Round 2022-06-07 14:50
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting 2022-06-07 14:00
Nippon Express (Belgium) Opens Genk Logistics Centre 2022-06-07 14:00
Clean Shipping: Berge Bulk and Kongsberg Maritime join forces to advance marine decarbonisation 2022-06-07 14:00
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting 2022-06-07 14:00
Nippon Express (Belgium) Opens Genk Logistics Centre 2022-06-07 14:00
ALE Device introduces a high-end 5-inch IPS SIP DeskPhone with built-in 2.5/5G Wi-Fi and Bluetooth 5.0 2022-06-07 13:13
GARNIER MALAYSIA KICKS OFF GARNIER GREEN BEAUTY INITIATIVE WITH PANTAI REMIS BEACH CLEANUP 2022-06-07 12:23
SCG Cell Therapy And A*STAR's IMCB Collaborate To Accelerate Clinical Translation of Immune Cell-based Therapy 2022-06-07 12:23
ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies 2022-06-07 11:30
CapitaLand Investment acquires 22-storey office tower in Melbourne's CBD 2022-06-07 11:29
ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3% 2022-06-07 11:28
IUCN and Huawei call for greater technology adoption to protect nature 2022-06-07 10:30
1 958 959 960 961 962 3443